 Nuclear Proteins
"Nuclear Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
| Descriptor ID |
D009687
|
| MeSH Number(s) |
D12.776.660
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nuclear Proteins".
Below are MeSH descriptors whose meaning is more specific than "Nuclear Proteins".
This graph shows the total number of publications written about "Nuclear Proteins" by people in this website by year, and whether "Nuclear Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 | | 1997 | 7 | 2 | 9 | | 1998 | 7 | 4 | 11 | | 1999 | 7 | 5 | 12 | | 2000 | 11 | 6 | 17 | | 2001 | 12 | 3 | 15 | | 2002 | 12 | 3 | 15 | | 2003 | 10 | 9 | 19 | | 2004 | 6 | 8 | 14 | | 2005 | 7 | 8 | 15 | | 2006 | 7 | 12 | 19 | | 2007 | 7 | 7 | 14 | | 2008 | 9 | 8 | 17 | | 2009 | 10 | 7 | 17 | | 2010 | 8 | 5 | 13 | | 2011 | 9 | 8 | 17 | | 2012 | 9 | 8 | 17 | | 2013 | 16 | 8 | 24 | | 2014 | 23 | 9 | 32 | | 2015 | 16 | 13 | 29 | | 2016 | 17 | 7 | 24 | | 2017 | 13 | 12 | 25 | | 2018 | 9 | 10 | 19 | | 2019 | 6 | 6 | 12 | | 2020 | 7 | 6 | 13 | | 2021 | 9 | 6 | 15 | | 2022 | 4 | 11 | 15 | | 2023 | 1 | 6 | 7 | | 2024 | 7 | 10 | 17 | | 2025 | 8 | 1 | 9 | | 2026 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Nuclear Proteins" by people in Profiles.
-
Taylor ER, Proctor B, Vaurs M, Wu G, Mahieu M, Shrestha S, Morrison D, Weatherly L, Brelinsky S, Raghunandan M, Decottignies A, Arnoult N. Local heterochromatin enrichment promotes telomere clustering and PML nuclear body assembly at telomeres. Cell Rep. 2026 Mar 24; 45(3):117004.
-
Zych MG, Contreras M, Mammel AE, Hatch EM. RCC1 depletion drives protein transport defects and rupture in micronuclei. J Cell Biol. 2026 Apr 06; 225(4).
-
Nelson CB, Wells JK, Kesarwani E, Sobinoff AP, Fernando M, Gao J, MacKenzie KL, Poulos RC, Nawaz U, Wang X, Ford HL, Pickett HA. Potent synthetic lethality between PLK1 and EYA family inhibitors in tumors of the central and peripheral nervous systems. Genes Dev. 2026 Feb 02; 40(3-4):267-283.
-
Byrom L, Turvey GL, Dowle AA, Thomas M, Shirodkar N, Green BJ, Brown M, Ball C, Chapman KE, Guglielmi E, Dickson W, Noon E, Sofi S, Ainscough JF, Antson AA, Coverley D. AURKB-driven dissolution of CIZ1-RNA assemblies from the inactive X chromosome in mitosis. Nucleic Acids Res. 2026 Jan 22; 54(3).
-
Haanpää MK, Haldeman-Englert CR, Hietala M, Tanverdi MS, Koty PP, Brightman D, Dosunmu E, Tibrewal S, Kaur S, Kaur A, Verma RK, de Alba Campomanes AG, Utz V, Slavotinek AM, Curry C. Nance-Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes. Am J Med Genet A. 2026 Mar; 200(3):642-652.
-
Rudolph J, Luger K. Histone PARylation factor 1: a review of its role in the DNA damage response. Nucleic Acids Res. 2025 Oct 28; 53(20).
-
Arellano ML, Thirman MJ, DiPersio JF, Heiblig M, Stein EM, Schuh AC, ?ucenka A, de Botton S, Grove CS, Mannis GN, Papayannidis C, Perl AE, Issa GC, Aldoss I, Bajel A, Dickens DS, Kühn MWM, Mantzaris I, Raffoux E, Traer E, Amitai I, Döhner H, Greco C, Kovacsovics T, McMahon CM, Montesinos P, Pigneux A, Shami PJ, Stone RM, Wolach O, Harpel JG, Chudnovsky Y, Yu L, Bagley RG, Smith AR, Blachly JS. Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study. Blood. 2025 Aug 28; 146(9):1065-1077.
-
de Sousa GR, Calzadilla AJ, Grimaldo E, Donson AM, Sobral LM, Jones KM, Liu T, Amani V, Venkataraman S, Dahl NA, Levy JMM, Phang T, Vibhakar R, Hankinson T, Handler M, Valera ET, Foreman NK, Griesinger AM. Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth. Neuro Oncol. 2025 Jul 30; 27(6):1597-1610.
-
Chan YS, Gao Q, Robinson SA, Wang W, Filandrova R, Weinhold LM, Cabrera ML, Zhang M, Ambati CSR, Lerario AM, Putluri N, Kiseljak-Vassiliades K, Wierman ME, Habra MA, Hammer GD, Veverka V, Cermakova K, Hodges HC. ß-catenin functions as a molecular adapter for disordered cBAF interactions. Mol Cell. 2025 Aug 21; 85(16):3041-3056.e9.
-
Guo XS, Khalifa A, Selvam K, Kutateladze TG, Liu WR. Development of Chemical Tools for the Human YEATS Domain. ACS Chem Biol. 2025 Aug 15; 20(8):1828-1840.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|